158 related articles for article (PubMed ID: 17964916)
21. Clinical inquiries. What are effective medication combinations for dyslipidemia?
Saseen J; Tweed E; Crawford P
J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
[No Abstract] [Full Text] [Related]
22. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
[TBL] [Abstract][Full Text] [Related]
23. Perspectives on dyslipidemia and coronary heart disease in women: an update.
Bittner V
Curr Opin Cardiol; 2006 Nov; 21(6):602-7. PubMed ID: 17053411
[TBL] [Abstract][Full Text] [Related]
24. Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort).
Gardette V; Bongard V; Dallongeville J; Arveiler D; Bingham A; Ruidavets JB; Amouyel P; Haas B; Ducimetière P; Ferrières J
Am J Cardiol; 2009 Feb; 103(3):381-6. PubMed ID: 19166693
[TBL] [Abstract][Full Text] [Related]
25. The use of lipid-lowering drug therapy in children and adolescents.
Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
[TBL] [Abstract][Full Text] [Related]
26. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
Marrs JC; Saseen JJ
Pharmacotherapy; 2008 May; 28(5):562-9. PubMed ID: 18447654
[TBL] [Abstract][Full Text] [Related]
27. Lipids, statins and cardiovascular disease.
Cheifitz R
Climacteric; 2008 Aug; 11(4):347-8; author reply 348-50. PubMed ID: 18645702
[No Abstract] [Full Text] [Related]
28. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
[No Abstract] [Full Text] [Related]
29. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
Ponte B; Bourquin V; Stoermann-Chopard C
Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
[TBL] [Abstract][Full Text] [Related]
30. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus.
Tahrani AA
Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848
[No Abstract] [Full Text] [Related]
31. Management of dyslipidemia in patients after solid organ transplantation.
Tannock LR; Reynolds LR
Postgrad Med; 2008 Apr; 120(1):43-9. PubMed ID: 18467808
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of dyslipidemia in post-infarction: state of the art].
Borgia MC; Nardi M; Da Ros S; Castellano V
Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719
[TBL] [Abstract][Full Text] [Related]
33. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
34. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.
Ali YS; Linton MF; Fazio S
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):142-6. PubMed ID: 18316949
[TBL] [Abstract][Full Text] [Related]
35. How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?
Rizzo M; Berneis K; Carmina E; Rini GB
Am J Obstet Gynecol; 2008 Jan; 198(1):28.e1-5. PubMed ID: 18166299
[TBL] [Abstract][Full Text] [Related]
36. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
37. Lipid abnormalities and cardiovascular risk in the elderly.
Milionis HJ; Elisaf MS; Mikhailidis DP
Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195
[TBL] [Abstract][Full Text] [Related]
38. Management of dyslipidemia with statins in the patient with peripheral arterial disease.
Blum AS
Tech Vasc Interv Radiol; 2006 Jun; 9(2):50-5. PubMed ID: 17482100
[TBL] [Abstract][Full Text] [Related]
39. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
40. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
Robson J
Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
